Related Experiment Video
Updated: Jan 10, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Therapeutic Considerations in Preventing Chronic Kidney Disease
Susanne B Nicholas1, Niloofar Nobakht1, Radica Z Alicic2,3
1Division of Nephrology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California, USA;
Early screening for chronic kidney disease (CKD) is crucial as most patients are unaware. Advanced therapies and multidisciplinary care are revolutionizing CKD management and reducing cardiovascular risks.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Background:
- Chronic kidney disease (CKD) impacts millions, yet diagnosis rates are low due to asymptomatic progression.
- Cardiovascular disease is the leading cause of mortality in CKD patients.
- Cardiovascular-kidney-metabolic syndrome underscores the interconnectedness of heart, kidney, and metabolic health.
Purpose of the Study:
- To emphasize the importance of early CKD screening in at-risk populations.
- To highlight the role of diagnostic markers in CKD staging and risk assessment.
- To discuss advancements in CKD management and the integrated care approach.
Main Methods:
- Utilizing urine albumin-to-creatinine ratio and estimated glomerular filtration rate for CKD classification and risk stratification.
- Reviewing current guideline-directed medical therapies and standard-of-care treatments.
- Examining the impact of cardiovascular-kidney-metabolic syndrome on organ health.
Main Results:
- Urine albumin-to-creatinine ratio and estimated glomerular filtration rate effectively classify CKD stages and predict progression risk.
- Novel therapies like SGLT2 inhibitors and GLP-1 receptor agonists, alongside ACE inhibitors/ARBs, significantly improve CKD outcomes.
- A multidisciplinary approach is optimal for managing complex CKD cases.
Conclusions:
- Prompt CKD screening is essential for early intervention and improved patient outcomes.
- Integrated management of cardiovascular, kidney, and metabolic disorders is critical.
- Modern pharmacotherapies and collaborative care models represent a paradigm shift in CKD treatment.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease I: Introduction
Acute Kidney Injury V: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations

